TD-8954

Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders
Yahoo
Wed, 06/8/16 - 09:58 am
Takeda
Theravance
TD-8954
gastrointestinal motility disorders